Page last updated: 2024-11-02

oxidopamine and Anemia

oxidopamine has been researched along with Anemia in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Obayashi, K1
Ando, Y1
Terazaki, H1
Yamashita, T1
Nakamura, M1
Suga, M1
Uchino, M1
Ando, M1

Other Studies

1 other study available for oxidopamine and Anemia

ArticleYear
Mechanism of anemia associated with autonomic dysfunction in rats.
    Autonomic neuroscience : basic & clinical, 2000, Aug-14, Volume: 82, Issue:3

    Topics: Adrenergic beta-Antagonists; Anemia; Animals; Autonomic Nervous System Diseases; Blood Cell Count; B

2000